Featured Research

from universities, journals, and other organizations

Daily Or Near-Daily Headache Is Surprisingly Common In The General Population

Date:
July 1, 1998
Source:
Johns Hopkins School Of Public Health
Summary:
More than four percent of the U.S. population suffers from "frequent headaches," defined as headaches that occur at least 180 days a year, according to researchers at the Johns Hopkins School of Public Health.

More than four percent of the U.S. population suffers from "frequent headaches," defined as headaches that occur at least 180 days a year, according to researchers at the Johns Hopkins School of Public Health and presented June 26 at the 40th annual scientific meeting of the American Association for the Study of Headache (AASH), San Francisco. This survey also found that frequent headaches were nearly twice as common among women as men. Caucasians had headaches more often than African Americans, and those with less than a high-school education suffered from headaches more than those with higher levels of education.

Lead author Ann I. Scher, MS, a doctoral student in the Department of Epidemiology at the Johns Hopkins School of Public Health, said, "Although frequent or daily headache is surprisingly common, relatively little is known about the scope and distribution of the public health problem posed by this type of headache."

The survey involved 13,343 demographically diverse individuals aged 18 to 65 years who were selected by computerized random-digit dialing and interviewed about the symptoms, duration, and occurrence of their headaches. All those who reported having 180 or more non-migraine headaches per year were classified as having "frequent headache" and were interviewed at length.

Ms. Scher and principal investigator Walter Stewart, PhD, MPH, Department of Epidemiology, Johns Hopkins School of Public Health, subdivided frequent headaches into three types: frequent headache with migrainous features (FH/M), chronic tension-type headache (CTTH), and unclassified frequent headache (FH/O).

The data revealed that 4.1 percent of the population (5 percent of women and 2.8 percent of men) suffered from frequent headache. Frequent headache was 33 percent more common among Caucasians (4.4 percent) than African Americans (3.3 percent); and, among both genders, frequent headaches were most common among those with less than a high school education.

The most common form of frequent headache in the study was chronic tension-type headache (CTTH), prevalent in 2.2 percent of the participants and accounting for 53 percent of the frequent headaches suffered.

In contrast to migraine, in which the prevalence generally peaks in the 40s and declines thereafter, the prevalence of frequent headache did not show any clear associations with age.

Approximately seven million adults in the United States suffer from headaches at least every other day, accounting for millions of work days missed or reduced efficiency while at work. Studies in clinics have identified potential risk factors for frequent headaches, including overuse of painkillers, depression, insomnia, or stressful or traumatic life events. In clinics, most of those with frequent headache have what is called "transformed migraine headaches," often associated with analgesic overuse. These potential risk factors for frequent headaches, however, have not been tested in population-based samples and may not be associated with frequent headache in the general population.


Story Source:

The above story is based on materials provided by Johns Hopkins School Of Public Health. Note: Materials may be edited for content and length.


Cite This Page:

Johns Hopkins School Of Public Health. "Daily Or Near-Daily Headache Is Surprisingly Common In The General Population." ScienceDaily. ScienceDaily, 1 July 1998. <www.sciencedaily.com/releases/1998/07/980701081945.htm>.
Johns Hopkins School Of Public Health. (1998, July 1). Daily Or Near-Daily Headache Is Surprisingly Common In The General Population. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/1998/07/980701081945.htm
Johns Hopkins School Of Public Health. "Daily Or Near-Daily Headache Is Surprisingly Common In The General Population." ScienceDaily. www.sciencedaily.com/releases/1998/07/980701081945.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins